MindImmune Therapeutics, Inc. funding
MindImmune Therapeutics, Inc., a pharmaceuticals company based in Kingston, RI, filed a Form D with the SEC on December 5, 2025 and reported $10.2M raised of a $12M offering.
Amount raised$10.2M
Offering size$12M
Filed with the SECDecember 5, 2025
First saleNovember 24, 2025
IndustryPharmaceuticals
SecuritiesEquity, Security to be acquired on exercise
LocationKingston, RI
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far14
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 5